Iomeron (Iomeprol)

Iomeron, an iodinated contrast agent, is employed in imaging procedures that require enhanced visualization of vascular structures and organs.

• Angiography: Improves delineation of blood vessels during catheter‑based imaging.
• Computed Tomography (CT) imaging: Increases contrast between tissues to aid diagnosis of abdominal, thoracic and cranial conditions.
• Vascular imaging procedures: Enhances detection of arterial and venous abnormalities in peripheral and central circulations.

• Iomeprol contains a high concentration of iodine atoms that absorb X‑ray photons, thereby increasing radiodensity of blood and extracellular fluids. After intravenous or intra‑arterial injection, the agent distributes rapidly within the vascular compartment and interstitial space, providing transient contrast enhancement. Its low protein binding and short plasma half‑life allow rapid clearance through renal excretion, producing a temporary but pronounced difference in attenuation between enhanced structures and surrounding tissues.

Iomeron may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Warm sensation or flushing: transient feeling of heat during injection.
• Nausea or vomiting: mild gastrointestinal upset.
• Metallic taste: brief alteration of taste perception.

Serious or Rare Side Effects

• Anaphylactic reaction: severe allergic response requiring immediate medical intervention.
• Acute renal failure: sudden loss of kidney function, especially in patients with pre‑existing renal impairment.
• Thyroid dysfunction: hyper‑ or hypothyroidism due to iodine load.

Before administering Iomeron, clinicians should observe several precautionary measures.

• Assess renal function: evaluate creatinine clearance prior to use.
• Screen for iodine allergy: obtain a detailed history of previous contrast reactions.
• Use lowest effective dose: limit exposure to the volume required for diagnostic quality.
• Monitor thyroid status: consider baseline assessment in patients with known thyroid disease.
• Avoid in severe dehydration: ensure adequate hydration before the procedure.
• Store at room temperature: keep in original container, protect from light and moisture.

Iomeron can interact with certain medications, necessitating careful review.

Major Interactions (Avoid)

• Metformin: risk of lactic acidosis; discontinue before and after contrast exposure.
• Nephrotoxic drugs (e.g., aminoglycosides, amphotericin B): may exacerbate renal injury.
• Radioactive iodine therapy: interference with thyroid imaging and function.

Moderate Interactions (Monitor Closely)

• NSAIDs: can affect renal perfusion; monitor kidney function.
• Diuretics: may increase dehydration risk; ensure adequate fluid intake.
• ACE inhibitors or ARBs: may potentiate contrast‑induced nephropathy; consider temporary suspension.